5 Patents
- US122204442025Treatment of Hyperinsulinemic Hypoglycemia with GLP-1 Antagonist Exendin(9-39)
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
0 cites - US121026632024Treatment of Post-bariatric Hypoglycemia with Exendin (9-39)
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US117380862023Methods of Using Buffered Formulations of Exendin (9-39)
Eiger Biopharmaceuticals, Inc.
0 cites - US116229952023Treatment of Post-bariatric Hypoglycemia with GLP-1 Antagonists
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
0 cites - US116177822023Treatment of Post-bariatric Hypoglycemia with Exendin (9-39)
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
0 cites